HSBC Holdings
CRL icon

HSBC Holdings’s Charles River Laboratories CRL Stock Holding History

HSBC Holdings’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,522
Closed -$107K – 1968
2015
Q2 		$107K Buy
+1,522
New +$113K ﹤0.01% 1914

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HSBC Holdings's CRL Position: Q1 2026 in Review

HSBC Holdings increased its Charles River Laboratories (CRL) stake by 12% in Q1 2026, buying an estimated $1.41M and bringing the position to 69,682 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #883.

HSBC Holdings first reported a position in CRL in Q1 2015 and has held it in 45 quarters since. The position peaked at $20.9M in Q1 2024. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • HSBC Holdings held 69,682 shares of Charles River Laboratories worth $12M as of Q1 2026.
  • HSBC Holdings bought 7,598 Charles River Laboratories shares in Q1 2026, an estimated $1.41M.
  • Charles River Laboratories made up 0.01% of HSBC Holdings's portfolio in Q1 2026, its #883 holding.
  • HSBC Holdings first reported a position in Charles River Laboratories in Q1 2015 and has held it in 45 quarters since.
  • HSBC Holdings's Charles River Laboratories position peaked at $20.9M in Q1 2024.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.